Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement
Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center
R01 and P01 Grants Will No Longer Support Phase III Clinical Trials
House Committee Seeks Review Of Indirect Costs Of NIH Grantees
Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says
